Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00442351Phase 4Terminated
Phase 4, randomised, double-blind trial in asthma comparing Asmanex Twisthaler with Placebo (2 arms). Primary endpoint: Forced Expiratory Volume in 1 Second at 12 weeks. Started Sep 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00442351.